4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-018021
CEO and CFO bought 1,000 shares at $11.69 ($11,690)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-05-17 | Purchase | +1,000 | $11.69 | $11,690 | 5,287,177 | D |
| Open-market purchases · 1,000 sh · avg $11.69 · $11,690 | |||||||
Loading xslF345X04/ownership.xml…